Liquisolid technique as a tool for enhancement of poorly water-soluble drugs and evaluation of their physicochemical properties

Acta Pharmaceutica

Volumn 57, Issue 1, 2007, Pages 99-109

  Javadzadeh, Yousef ^a   Siahi, Mohammad Reza ^a   Asnaashari, Solmaz ^a   Nokhodchi, Ali ^a,b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MEDWAY SCHOOL OF PHARMACY   (United Kingdom)

Author keywords

Aging; Dissolution rate; DSC; Indomethacin; Liquisolid compacts; XPD

Indexed keywords

INDOMETACIN; MACROGOL 400; MICROCRYSTALLINE CELLULOSE; POLYSORBATE 80; PROPYLENE GLYCOL; SILICON DIOXIDE;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DOSAGE FORM COMPARISON; DRUG FORMULARY; DRUG SOLUBILITY; INTESTINE FLUID; LIQUISOLID TABLET; STOMACH; STOMACH PH; TABLET; X RAY POWDER DIFFRACTION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALORIMETRY, DIFFERENTIAL SCANNING; HYDROGEN-ION CONCENTRATION; INDOMETHACIN; PHARMACEUTICAL PREPARATIONS; SOLUBILITY; SOLVENTS; SPECTROPHOTOMETRY, ULTRAVIOLET; TABLETS; X-RAY DIFFRACTION;

EID: 33847617927     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10007-007-0008-6     Document Type: Article

References (21)

1. S. G. Kapsi and J. W. Ayres, Processing factors in development of solid solution formulation of itraconazole for enhancement of drug dissolution and bioavailability, Int. J. Pharm. 229 (2001) 193-203.
2. A. J. Aguiar, A. J. Zelmer and A. W. Kinkel, Deagglomeration behavior of relatively insoluble benzoic acid and its sodium salt, J. Pharm. Sc. 56 (1967) 1243-1252.
3. P. Finholt and S. Solvang, Dissolution kinetics of drugs in human gastric juice; the role of surface tension, J. Pharm. Sci. 57 (1968) 1322-1326.
4. S. L. Lin, J. Menig and L. Lachman, Interdependence of physiological surfactant and drug particle size on the dissolution behavior of water insoluble drugs, J. Pharm. Sci. 57 (1968) 2143-2146.
5. S. Spireas and S. Sadu, Enhancement of prednisolone dissolution properties using liquisolid compacts, Int. J. Pharm. 166 (1998) 177-188.
6. S. Spireas, S. Sadu and R. Grover, In vitro release evaluation of hydrocortisone liquisolid tablets, J. Pharm. Sci. 87 (1998) 867-872.
7. S. Spireas, T. Wang and R. Grover, Effect of powder substrate on the dissolution properties of methchrothiazide liquisolid compacts, Drug Dev. Ind. Pharm. 25 (1999) 163-168.
8. K. Y. Yang, R. Glemza and C. I. Jarowski, Effect of amorphous silicon dioxide on drug dissolution, J. Pharm. Sci. 68 (1979) 560-565.
9. C. Liao and C. I. Jarowski, Dissolution rates of corticoid solutions dispersed on silicas, J. Pharm. Sci. 73 (1984) 401-403.
10. A. Nokhodchi, Y. Javadzadeh, M. R. Siahi and M. Barzegar-Jalali, The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts, J. Pharm. Pharm. Sci. 8 (2005) 18-25.
11. United States Pharmacopocia 26, Natural Formulary 21, USP Convention, Rockville 2003.
12. P. Costa, An alternative method to the evaluation of similarity factor in dissolution testing, Int. J. Pharm. 220 (2001) 77-83.
13. P. Costa and J. M. S. Lobo, Modelling and comparison of dissolution profiles, Eur. J. Pharm. Sci. 13 (2001) 123-133.
14. K. A. Khan, Concept of dissolution efficiency, J. Pharm. Pharmacol. 27 (1975) 48-49.
15. H. Abdou, Effect of the physicochemical properties of the drug on dissolution in Dissolution, Bioavailability and Bioequivalence (Ed. H. Abdou), Edison Mack Publishing Co., Easton, PA 1989, pp. 53-72.
16. N. Kaneniwa, M. Otsuka and T. Hayashi, Physicochemical characterization of indomethacin polymorphs and transformation kinetics in ethanol, Chem. Pharm. Bull. 33 (1985) 3447-3455.
17. H. Imaizumi, N. Nambu and T. Nagai, Stability of several physical properties of amorphous and crystalline forms of indomethacin, Chem. Pharm. Bull. 28 (1980) 2565-2569.
18. L. Borka, Polymorphism of indomethacin. New modifications, their melting behavior and solubility, Acta Pharm. Suecica 11 (1974) 295-303.
19. M. Otsuka, F. Kato and Y. Matsuda, Determination of indomethacin polymorphic contents by chemometric near-infrared spectroscopy and conventional powder X-ray diffractometry, Analyst 126 (2001) 1578-1582.
20. M. Yoshioka, B.C. Hancock and G. Zografi, Crystallization of indomethacin from the amorphous state below and above its glass transition temperature, J. Pharm. Sci. 83 (1994) 1700-1705.
21. H. Imaizumi, N. Nambu and T. Nagai, Stabilization of amorphous state of indomethacin by solid dispersions in polyvinylpyrolidone, Chem. Pharm. Bull. 31 (1983) 2510-2512.